Ascvd risk calculator mdcalc
Author: n | 2025-04-25
ASCVD risk calculator MDCalc在ASCVD Risk Estimator - Mobile and Web Apps的討論與評價. Estimate patient's 10-year ASCVD risk at an initial visit to establish a reference point. Forecast the potential impact of different interventions on patient
Ascvd Risk Calculator Mdcalc - Mirmgate
Etc.2 This patient is at intermediate 10-year risk (7.5% to For patients 40-74 years old with diabetes, a moderate intensity statin can be considered regardless of ASCVD risk. In patients with multiple risk factors, it is reasonable to use high-intensity statin therapy to reduce LDL-C by ≥ 50% About This Calculator This peer-reviewed online calculator uses the Pooled Cohort Equations to estimate the 10-year primary risk of ASCVD (atherosclerotic cardiovascular disease) among patients without pre-existing cardiovascular disease who are between 40 and 79 years of age.1 Patients are considered to be at "elevated" risk if the Pooled Cohort Equations predicted risk is ≥ 7.5% (possibly ≥ 5%). In many ways, the Pooled Cohort Equations have been proposed to replace the Framingham Risk 10-year CVD calculation, which was recommended for use in the NCEP ATP III guidelines for high blood cholesterol in adults.3 Current guidelines for the treatment of cholesterol to reduce cardiovascular risk recommend that the following four groups of patients will benefit from moderate- or high-intensity statin therapy:2 Individuals with clinical ASCVD Individuals with primary elevations of LDL ≥ 190 mg/dL Individuals 40 to 75 years of age with diabetes and an LDL 70 to 189 mg/dL without clinical ASCVD Individuals without clinical ASCVD or diabetes who are 40 to 75 years of age with LDL 70 to 189 mg/dL and a 10-year ASCVD risk of 5-7.5% or higher As shown above, among patients who do not otherwise have a compelling indication for statin therapy, the Pooled Cohort Equations can be used to estimate primary cardiovascular risk and potential benefit from statin therapy. What is ASCVD? ASCVD stands for atherosclerotic cardiovascular disease, defined as a nonfatal myocardial infarction (heart attack), coronary heart disease death, or stroke. The purpose of the Pooled Cohort Equations is to estimate the risk of. ASCVD risk calculator MDCalc在ASCVD Risk Estimator - Mobile and Web Apps的討論與評價. Estimate patient's 10-year ASCVD risk at an initial visit to establish a reference point. Forecast the potential impact of different interventions on patient The MHA with the highest MARS score was ESC CVD Risk Calculation (5 points), followed by ASCVD Risk Estimator Plus (4.9 points). In the IMS scale, four MHA had a high functionality score: ASCVD Risk Estimator Plus (5 points), ESC CVD Risk Calculation (5 points), MDCalc Medical Calculator (4 points), and Calculate by QsMD (4 points). The MHA with the highest MARS score was ESC CVD Risk Calculation (5 points), followed by ASCVD Risk Estimator Plus (4.9 points). In the IMS scale, four MHA had a high functionality score: ASCVD Risk Estimator Plus (5 points), ESC CVD Risk Calculation (5 points), MDCalc Medical Calculator (4 points), and Calculate by QsMD (4 points). Discussion ASCVD (Atherosclerotic Cardiovascular Disease) 2025 Risk Calculator from AHA/ACC. Determine 10-year risk of hard ASCVD, i.e. myocardial infarction, stroke, or death due to coronary heart disease or stroke. CME Stroke CME Physicians Guide EBM Guide. about About MDCalc Announcements MDCalc on Race FAQs Featured Press For Partners Contact Us. team The updated ASCVD Risk Estimator Plus uses up to date science and user feedback to help a clinician and patient build a customized risk lowering plan by estimating and monitoring change in 10-year ASCVD risk. MDCalc for Android When to perform ASCVD risk assessment; How to perform ASCVD risk assessments; Why assess ASCVD risk? Risk assessment in children and adolescents; HOW TO ASSESS ASCVD RISK. Identify risk factors; Identify risk-enhancing factors; Estimate ASCVD risk using a risk calculator - Choosing a risk calculator - Lifetime risk - 10-year risk versus 30-year Pooled cohort risk predicts 10-year risk for a first atherosclerotic cardiovascular disease (ASCVD) eventClinCalc.com » Cardiology » ASCVD Risk Calculator Risk Factors for ASCVD Gender Male Female Age years Race Total Cholesterol HDL Cholesterol Systolic BP mmHg Receiving treatment for high blood pressure (if SBP > 120 mmHg) No Yes Diabetes No Yes Smoker No Yes US units RESULTS Print ASCVD Risk Evaluation 10-year risk of atherosclerotic cardiovascular disease: 16.6% 10-year risk in a similar patient with optimal risk factors Total cholesterol of 170 mg/dL HDL cholesterol of 50 mg/dL Systolic BP of 110 mmHg Not taking medications for hypertension Not a diabetic Not a smoker ">: 3.6% Lifetime risk of atherosclerotic cardiovascular disease : 50%(95% CI 46% to 55%) Lifetime risk for a 50-year-old with optimal risk factors Total cholesterol less than 180 mg/dL Systolic BP less than 120 mmHg Not taking medications for hypertension Not a diabetic Not a smoker ">: 5%(95% CI 0% to 12%) ASCVD Risk Interpretation 1,2 Statin recommendations based on ASCVD risk is intended for patients age 40-75 years with LDL-C 70 to Low Risk ( Borderline Risk (5% to Intermediate Risk (≥ 7.5% to High Risk (≥ 20%) Emphasize healthy lifestyle factors to reduce risk factors (class I) Consider moderate-intensity statin if risk-enhancing factors† are present (class IIb) Consider moderate-intensity statin if risk-enhancing factors† are present (class I) Consider high-intensity statin (class I) † Risk-enhancing factors are a variety of factors known to increase future ASCVD risk but are not necessarily captured within the ASCVD calculation. Clinicians should use judgment when evaluating whether risk-enhancing factors favors statin initiation or not; there is no number of risk-enhancing factors that must be met to prompt statin initiation. These risk factors could include: family history of premature ASCVD, metabolic syndrome, chronic kidney disease, chronic inflammatory conditions,Comments
Etc.2 This patient is at intermediate 10-year risk (7.5% to For patients 40-74 years old with diabetes, a moderate intensity statin can be considered regardless of ASCVD risk. In patients with multiple risk factors, it is reasonable to use high-intensity statin therapy to reduce LDL-C by ≥ 50% About This Calculator This peer-reviewed online calculator uses the Pooled Cohort Equations to estimate the 10-year primary risk of ASCVD (atherosclerotic cardiovascular disease) among patients without pre-existing cardiovascular disease who are between 40 and 79 years of age.1 Patients are considered to be at "elevated" risk if the Pooled Cohort Equations predicted risk is ≥ 7.5% (possibly ≥ 5%). In many ways, the Pooled Cohort Equations have been proposed to replace the Framingham Risk 10-year CVD calculation, which was recommended for use in the NCEP ATP III guidelines for high blood cholesterol in adults.3 Current guidelines for the treatment of cholesterol to reduce cardiovascular risk recommend that the following four groups of patients will benefit from moderate- or high-intensity statin therapy:2 Individuals with clinical ASCVD Individuals with primary elevations of LDL ≥ 190 mg/dL Individuals 40 to 75 years of age with diabetes and an LDL 70 to 189 mg/dL without clinical ASCVD Individuals without clinical ASCVD or diabetes who are 40 to 75 years of age with LDL 70 to 189 mg/dL and a 10-year ASCVD risk of 5-7.5% or higher As shown above, among patients who do not otherwise have a compelling indication for statin therapy, the Pooled Cohort Equations can be used to estimate primary cardiovascular risk and potential benefit from statin therapy. What is ASCVD? ASCVD stands for atherosclerotic cardiovascular disease, defined as a nonfatal myocardial infarction (heart attack), coronary heart disease death, or stroke. The purpose of the Pooled Cohort Equations is to estimate the risk of
2025-04-25Pooled cohort risk predicts 10-year risk for a first atherosclerotic cardiovascular disease (ASCVD) eventClinCalc.com » Cardiology » ASCVD Risk Calculator Risk Factors for ASCVD Gender Male Female Age years Race Total Cholesterol HDL Cholesterol Systolic BP mmHg Receiving treatment for high blood pressure (if SBP > 120 mmHg) No Yes Diabetes No Yes Smoker No Yes US units RESULTS Print ASCVD Risk Evaluation 10-year risk of atherosclerotic cardiovascular disease: 16.6% 10-year risk in a similar patient with optimal risk factors Total cholesterol of 170 mg/dL HDL cholesterol of 50 mg/dL Systolic BP of 110 mmHg Not taking medications for hypertension Not a diabetic Not a smoker ">: 3.6% Lifetime risk of atherosclerotic cardiovascular disease : 50%(95% CI 46% to 55%) Lifetime risk for a 50-year-old with optimal risk factors Total cholesterol less than 180 mg/dL Systolic BP less than 120 mmHg Not taking medications for hypertension Not a diabetic Not a smoker ">: 5%(95% CI 0% to 12%) ASCVD Risk Interpretation 1,2 Statin recommendations based on ASCVD risk is intended for patients age 40-75 years with LDL-C 70 to Low Risk ( Borderline Risk (5% to Intermediate Risk (≥ 7.5% to High Risk (≥ 20%) Emphasize healthy lifestyle factors to reduce risk factors (class I) Consider moderate-intensity statin if risk-enhancing factors† are present (class IIb) Consider moderate-intensity statin if risk-enhancing factors† are present (class I) Consider high-intensity statin (class I) † Risk-enhancing factors are a variety of factors known to increase future ASCVD risk but are not necessarily captured within the ASCVD calculation. Clinicians should use judgment when evaluating whether risk-enhancing factors favors statin initiation or not; there is no number of risk-enhancing factors that must be met to prompt statin initiation. These risk factors could include: family history of premature ASCVD, metabolic syndrome, chronic kidney disease, chronic inflammatory conditions,
2025-04-12ASCVD within a 10-year period among patients who have never had one of these events in the past. Impact of Race on the Pooled Cohort Equations The Pooled Cohort Equations were developed and validated among Caucasian and African American men and women who did not have clinical ASCVD. There are inadequate data in other racial groups, such as Hispanics, Asians, and American-Indian populations. Given the lack of data, current guidelines suggest to use the "Caucasian" race to estimate 10-year ASCVD risk with the knowledge that further research is needed to stratify these patients' risk. Compared to Caucasians, the risk of ASCVD is generally lower among Hispanic and Asian populations and generally higher among American-Indian populations. Statin Regimens The 2019 ACC/AHA guidelines recommend either a high-intensity or moderate-intensity statin regimen in patients who have an elevated ASCVD risk (≥ 5-7.5%) for primary prevention of cardiovascular disease. The recommended doses for each of these regimens are shown below: High-Intensity(>50% LDL-C Reduction) Moderate-Intensity(30% to 50% LDL-C Reduction) Low-Intensity( Atorvastatin 40 to 80 mg 10 to 20 mg ‐ Rosuvastatin 20 to 40 mg 5 to 10 mg ‐ Simvastatin ‐ 20 to 40 mg 10 mg Fluvastatin ‐ 40 mg BID / 80 mg XL 20 to 40 mg Lovastatin ‐ 40 to 80 mg 20 mg Pitavastatin ‐ 1 to 4 mg ‐ Pravastatin ‐ 40 to 80 mg 10 to 20 mg Citations: (1) Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082‐e1143. doi:10.1161/CIR.0000000000000625. (2) Chou R, Dana T, Blazina I, et al. Statin Use for the Prevention of Cardiovascular Disease in Adults: A Systematic Review for the U.S. Preventive Services Task Force [Internet]. Rockville
2025-04-14(MD): Agency for Healthcare Research and Quality (US); 2016 Nov. (Evidence Syntheses, No. 139.) Table 1, Statin Dosing and ACC/AHA Classification of Intensity. Available from: How was the Pooled Cohort Equations Model Developed? The Pooled Cohort Risk Assessment Equations was developed by the Risk Assessment Work Group, an arm of the ACC/AHA Cardiovascular Risk Guidelines, to identify appropriate candidates for statin therapy based on elevated cardiovascular risk.1 Statistical modeling to create a new risk assessment tool was developed using a variety of participants from several large, diverse NHLBI-sponsored studies. Population Distribution of the Pooled Cohort Equations Lifetime ASCVD Risk In individuals aged 20 to 59 years of age, a lifetime risk assessment is mentioned by guidelines (with a 'low' strength of evidence).1 A long-term risk assessment may be more accurate in younger individuals free from ASCVD (eg, 20 to 59 years old). This lifetime estimation was based on a paper published in 2006 that was developed by assigning a patient into one of five mutually exclusive sex-specific groups.4 In some cases, the 10-year ASCVD risk may be higher than lifetime risk due to differing mathematical approaches. If this is the case, the 10-year risk should be the primary focus for risk identification. References and Additional Reading 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk. doi: 10.1161/01.cir.0000437741.48606.98.Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. PMID 30879355.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486-97.
2025-04-18Check your knowledge; updated clinical entries and current strategies for treatment; and a drug resource center. Oh, and it’s free with no ads.Best Medical Translator App for Nurses11. Care to TranslateAvailable for Download On: Apple App Store | Google PlayWhy You’ll Love It: Ever been faced with non-English-speaking patients and not have a translator available? That’s when the Care to Translate app is the rapid reference you can rely on. Available both for healthcare staff and patients, this medical translator app is available in over 40 languages. All medical terms and phrases have been verified by both healthcare professionals and native speakers, so you never have to worry about getting your patient the information they need.Best Calculator Apps for Nurses12. MDCalc Medical CalculatorAvailable for Download On: Apple App Store | Google PlayWhy You’ll Love It: With more than 48,000 App Store ratings and a near-perfect score of 4.9, this app has helped millions of medical professionals in their clinical practices. It offers several calculators that work even offline and in limited connection places. A customizable feature allows you to quickly access your favorites, recent visits, or calculators designed for your specialty. Additionally, it provides access to more than 550 easy-to-use clinical decision tools like risk evaluations, algorithms, and dosing calculators.13. Calculate by QxMDAvailable for Download On: Apple App Store | Google PlayWhy You’ll Love It: Calculate by QxMD does more than help with calculations. It enables you to use point-of-care tools based on your areas of expertise, whether cardiology, respiratory, vascular surgery, or others. The app uses a question flow technology uniquely designed to get fast and accurate answers. More than anything, Calculate works to help you make decisions about your patient’s care instead of just calculating the numbers.Best Scheduling App for Nurses14. NurseGrid SchedulingAvailable for Download On: Apple App Store | Google PlayWhy You’ll Love It: In nursing, you have to prioritize your work-life balance. The NurseGrid scheduling app helps you do just that. You can carry your work schedule with you everywhere and compare it with your co-workers’. If you need to swap a shift at the last
2025-03-30Risk management is one of a trader’s most crucial instruments. To manage risk and prevent blowing out your account on a single trade, proper position sizing is essential. Forex trading is now simpler than ever thanks to the position size calculator!The position size calculator can help you determine the approximate number of currency units to purchase or sell to control your maximum risk per position with just a few easy inputs. Enter the currency pair you are trading, the amount of your account, and the percentage of your account you want to risk into the position size calculator. Based on the data you enter, the position sizing calculator will make suggestions for position sizes.What is a Position Size Calculator?It might be an understatement to say that risk management is important for traders. It is unquestionably necessary for a trader to survive in the forex market, the truth be told. In the realm of trading, proper position sizing and risk management are frequently critical differentiators between amateurs and experts. With the aid of this forex position size calculator, you can manage your trading risk effectively and stake only a small portion of your trading account on each trade. You input the size of your trading account and the percentage of the account you are willing to risk on each transaction into the position size calculator to use it. The calculator will then show you the ideal position size for that specific transaction when you select the currency pair you want to trade.The position size calculator is an excellent resource for determining when to enter, when to withdraw, and how much to risk if you are incorrect. Numerous important Forex books emphasise the value of a rigorous position size calculating process. Setting the appropriate stop-loss and take-profit levels should be done in
2025-04-12